SCHEMBL31184485

SCHEMBL31184485

COc1cc(NC(=O)C2CCC(N3Cc4c(C)ccc(C=O)c4NC3=O)CC2)ccc1C

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CHKA P35790 1/20 0.39
▸ CHKB Q9Y259 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ ACHE P22303 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ TP53 P04637 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31184589 0.92 POLB (0.41) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184841 0.91 POLB (0.45) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184359 0.90 POLB (0.47) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184756 0.89 POLB (0.43) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184644 0.88 MAPT (0.43) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184623 0.87 POLB (0.42) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184731 0.86 POLB (0.41) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184586 0.86 POLB (0.41) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31184483 0.85 POLB (0.41) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL31185060 0.85 SMN1; SMN2 (0.47) POLBALDH1A1SMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024220626-A1 SMALL MOLECULE MODULATORS OF OGG1 AZKARRA THERAPEUTICS, INC. (US) 2024-10-24 — — WO disclosed
Send feedback